Dan Switzer Bio
Daniel Switzer
As Head of US Oncology Business Division, Dan is accountable for all US business, and he is responsible for the commercialization and performance of all in-line and near-term oncology assets. He oversees the Sales, Marketing, Market Access, Medical Affairs and Business Operations functions for the US. He also serves on the leadership team for the Global Oncology Business Unit. In addition to his responsibilities leading the Oncology Business Division, Dan is a member of the Daiichi Sankyo, Inc. Board of Directors.
Dan has been with Daiichi Sankyo since 2005, holding leadership roles in brand management, market access, and business analytics. Throughout his time at Daiichi Sankyo he has launched multiple pharmaceuticals and biologics and overseen multi large scale franchises. Since 2020, Dan has led the transformation of the Daiichi Sankyo US commercial and medical organization into an oncology company.
Dan leads with a passion to make Daiichi Sankyo a global leader in oncology and to change the standard of care and improve and extend the lives of cancer patients.